Skip to main content

Table 4 Comparison of clinical parameters analyzed and particular genotypes of the -197G > A IL-17 polymorphism in healthy women after menopause

From: Polymorphism of interleukin-17 and its relation to mineral density of bones in perimenopausal women

Parameter/genotype

GG

GA

AA

T-score

−0.19 ± 0.49

−0.01 ± 0.72

0.32 ± 0.47

Z-score

0.60 ± 0.93

0.63 ± 0.87

0.70 ± 0.72

Body mass (kg)

70.33 ± 9.80

67.07 ± 9.81

67.13 ± 8.56

Height (cm)

163.04 ± 5.66

163.58 ± 6.02

163.97 ± 5.92

Body mass index (kg/m2)

25.07 ± 4.07

25.73 ± 3.80

25.10 ± 4.40

Age

52.03 ± 7.60

50.32 ± 8.02

54.68 ± 7.90

Birth weight

3552.83 ± 517.35

3506.79 ± 440.31

3708.44 ± 501.71

Reproductive years

36.63 ± 5.06

36.04 ± 4.72

35.36 ± 4.77

Age of menarche

12.78 ± 1.68

13.92 ± 1.69

13.83 ± 1.88

Last menstrual period age

50.17 ± 4.58

52.16 ± 4.04

51.03 ± 5.03

Number of pregnancies

2.10 ± 1.06

2.06 ± 1.50

1.87 ± 1.26

Years after menopause

7.45 ± 6.06

7.58 ± 5.47

7.90 ± 6.15

BMD L2–L4 (g/cm2)

1.14 ± 0.09

1.26 ± 0.15

1.24 ± 0.11

BMD L2–L4 YA (%)

93.45 ± 8.57

99.52 ± 8.06

106.24 ± 7.52

BMD L2–L4 AM (%)

100.02 ± 9.12

106.30 ± 10.02

109.56 ± 9.52